Allison A Feduccia

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Smoking Cessation

Randomized Controlled Trial

Posttraumatic Stress Disorder

Top Venues

Psychopharmacology

Expert review of clinical pharmacology

Psychedelic.Support, Project New Day

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Psychedelic.Support, Project New Day Jan 21 2020

United States

Director

Publications

Allison A Feduccia, Lisa Jerome, Michael C Mithoefer, Julie Holland
Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy. Psychopharmacology (2024)
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology (2024)
Allison A Feduccia, Lisa Jerome, Michael C Mithoefer, Julie Holland
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy. Psychopharmacology 238 (2) (2020)
Kyle T Greenway, Nicolas Garel, Lisa Jerome, Allison A Feduccia
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. Expert review of clinical pharmacology 13 (6) (2020)
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology 236 (9) (2019)